If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 64   2003   NUMBER 11

Issue to be mailed the week of November 26, 2003

CME Pretest 1281

CME Posttest 1400

Brainstorms

1282 Symptoms and Circuits, Part 1: Major Depressive Disorder. Stephen M. Stahl
[PDF]

Original Articles

1284 The Relationship Between Postpartum Psychosis and Bipolar Disorder: A Review. Linda H. Chaudron and Ronald W. Pies
[Abstract] [PDF]

1293 Cost and Outcome Implications of Using Typical and Atypical Antipsychotics in Ordinary Practice in Italy. Mauro Percudani and Corrado Barbui
[Abstract] [PDF]

1300 Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients With and Without Obsessive-Compulsive Disorder: Schizophrenic and OC Symptoms in Schizophrenia. [CME] Michael Poyurovsky, Victoria Kriss, Gregory Weisman, Sarit Faragian, Rena Kurs, Michael Schneidman, Camil Fuchs, Abraham Weizman, and Ronit Weizman
[Abstract] [PDF]

1308 Partial Compliance and Patient Consequences in Schizophrenia: Our Patients Can Do Better. [CME] Samuel J. Keith and John M. Kane
[Abstract] [PDF]

1316 A Prospective, Open-Label, Flexible-Dose Study of Quetiapine in the Treatment of Delirium. Yukiya Sasaki, Tetsuaki Matsuyama, Seishiro Inoue, Tomoko Sunami, Takeshi Inoue, Kenzo Denda, and Tsukasa Koyama
[Abstract] [PDF]

1322 Escitalopram in the Treatment of Panic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. Stephen M. Stahl, Ivan Gergel, and Dayong Li
[Abstract] [PDF]

1328 Lithium Interaction With the Cyclooxygenase 2 Inhibitors Rofecoxib and Celecoxib and Other Nonsteroidal Anti-Inflammatory Drugs. Kathleen M. Phelan, Andrew D. Mosholder, and Susan Lu
[Abstract] [PDF]

1335 Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1: Improvement in Binge and Purge Measures. Scott P. Hoopes, Frederick W. Reimherr, Dawson W. Hedges, Norman R. Rosenthal, Marc Kamin, Rezaul Karim, Julie A. Capece, and Debra Karvois
[Abstract] [PDF]

1342 Risperidone for Severe Tardive Dyskinesia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study. Ya-Mei Bai, Shun-Chieh Yu, and Chao-Cheng Lin
[Abstract] [PDF]

1349 Long-Term Antidepressant Efficacy and Safety of Olanzapine/Fluoxetine Combination: A 76-Week Open-Label Study. Sara A. Corya, Scott W. Andersen, Holland C. Detke, Linda S. Kelly, Luann E. Van Campen, Todd M. Sanger, Douglas J. Williamson, and Sanjay Dube
[Abstract] [PDF]

1357 Psychiatric Comorbidity as a Predictor of Clinical Response to Nortriptyline in Treatment-Resistant Major Depressive Disorder. George I. Papakostas, Timothy J. Petersen, Amy H. Farabaugh, Jessica L. Murakami, Joel A. Pava, Jonathan E. Alpert, Maurizio Fava, and Andrew A. Nierenberg
[Abstract] [PDF]

1362 Prolactin Levels During Long-Term Risperidone Treatment in Children and Adolescents. Robert L. Findling, Vivek Kusumakar, Denis Daneman, Thomas Moshang, Goedele De Smedt, and Carin Binder
[Abstract] [PDF]

1370 The Attribution of Somatization in Schizophrenia Patients: A Naturalistic Follow-Up Study. Michael Ritsner
[Abstract] [PDF]

Academic Highlights

1379 New Developments in Antipsychotic Therapy. [CME]
[PDF]

Letters To the Editor

1391 Amitriptyline: Dual-Action Antidepressant? P. Ken Gillman
[PDF]

  • Dr. Thase Replies

1392 Can Donepezil Be Considered a Mild Antipsychotic in Dementia Treatment? A Report of Donepezil Use in 6 Patients. Takeshi Terao, Taito Shimomura, and Jun Nakamura
[PDF]

1393 Mania From Dose-Related Ziprasidone Augmentation of an SSRI. Michael R. Privitera and Kumar Maharaj
[PDF]

1394 Successful Treatment With Clozapine at Higher Doses After Clozapine-Induced Priapism. Alexander de Nesnera
[PDF]

Book Reviews 1396

NOW @ Psychiatrist.com 1403

Information for authors

see www.psychiatrist.com/author.htm for complete information